USAGE OF DRUGS IN EUROPE LSD CANNABIS

ALL ADULTS (15-64) USAGE OF LSD IN EUROPE All adults (15-64) Usage of LSD in Europe datesample sizemalefemaletotal Denmark %7.00%1.4% France %0.81%1.68% Germany %1.30%2.20% Ireland %2.20%4.40% Italy * %0.30%0.70% Norway Portugal %0.30%0.60% Spain Sweden United Kingdom * %2.90%5.10%

ALL ADULTS (15-64) USAGE OF LSD IN EUROPE MALE & FEMALE TOTAL AVERAGES

COUNTRIES WERE ASKED TO REPORT RESULTS USING, AS FAR AS POSSIBLE, EMCDDA STANDARD AGE GROUPS (ALL ADULTS: 15-64, YOUNG ADULTS: 15-34). IN COUNTRIES WHERE AGE RANGES ARE MORE RESTRICTIVE, PREVALENCE ESTIMATES MAY TEND TO BE SLIGHTLY HIGHER 'SAMPLE SIZE' REFERS TO THE NUMBER OF ACTUAL RESPONDENTS TO THE SURVEY (NET SAMPLE). IN SOME CASES, NATIONAL SURVEYS COVER ORIGINALLY A BROADER AGE RANGE ('ORIGINAL AGE RANGE') THAN THAT PRESENTED HERE FOR THE STANDARD GROUPS 'ALL ADULTS'(15-64) AND 'YOUNG ADULTS' (15-34). THIS TABLE PRESENTS THE RESULTS FOR THE LAST SURVEYS AVAILABLE IN EACH COUNTRY. IT AIMS TO PRESENT AN OVERVIEW OF NATIONAL SURVEYS. SOME CITY SURVEYS REPORTED BY COUNTRIES WERE NOT INCLUDED AS THEY TEND TO PRODUCE HIGHER PREVALENCE ESTIMATES WHICH ARE NOT COMPARABLE WITH ESTIMATES FOR WHOLE COUNTRIES (OR LARGE REGIONS WITH BOTH URBAN AND RURAL AREAS). ITALY: THE MOST RECENT GENERAL POPULATION SURVEY REPORTED BY ITALY DISPLAY A WIDE VARIATION IN RESULTS COMPARED WITH THE PREVIOUS SURVEYS WHICH MAY REFLECT METHODOLOGICAL DIFFERENCES. THE DATA IS PROVIDED FOR INFORMATION, BUT GIVEN THE LACK OF COMPARABILITY BETWEEN SURVEYS SHOULD BE TREATED WITH CAUTION.

YOUNG ADULTS (15-34) USAGE OF LSD IN EUROPE datesample sizemalefemalestotal Austria %1.10%1.90% Estonia Germany %1.50%3.00% Greece %0.20%0.40% Italy * %0.50%1.00% Latvia %0.60%1.30% Poland %0.30%1.00% Romania %0.10% Sweden Turkey

ALL ADULTS (15-34) USAGE OF LSD IN EUROPEEUROPE MALE & FEMALE TOTAL AVERAGES

COUNTRIES WERE ASKED TO REPORT RESULTS USING, AS FAR AS POSSIBLE, EMCDDA STANDARD AGE GROUPS (ALL ADULTS: 15-64, YOUNG ADULTS: 15-34). IN COUNTRIES WHERE AGE RANGES ARE MORE RESTRICTIVE, PREVALENCE ESTIMATES MAY TEND TO BE SLIGHTLY HIGHER. SOME COUNTRIES HAVE RECALCULATED THEIR PREVALENCE FIGURES USING THE EMCDDA STANDARD AGE GROUPS. 'SAMPLE SIZE' REFERS TO THE NUMBER OF ACTUAL RESPONDENTS TO THE SURVEY (NET SAMPLE). IN SOME CASES, NATIONAL SURVEYS COVER ORIGINALLY A BROADER AGE RANGE ('ORIGINAL AGE RANGE') THAN THAT PRESENTED HERE FOR THE STANDARD GROUPS 'ALL ADULTS'(15-64) AND 'YOUNG ADULTS' (15-34).

ALL ADULTS (15-64) USING CANNABIS IN EUROPE YearSample sizemalesfemalestotal Austria %11.00%14.20% Belgium %10.80%14.30% Bulgaria %4.200%7.50% Croatia %10.40%15.60% Denmark %29.70%35.60% Finland %14.50%18.30% France %24.95%32.12% Germany %18.60%23.10%

ALL ADULTS (15-64) USING CANNABIS IN EUROPE MALE & FEMALE TOTAL AVERAGES

COUNTRIES WERE ASKED TO REPORT RESULTS USING, AS FAR AS POSSIBLE, EMCDDA STANDARD AGE GROUPS (ALL ADULTS: 15-64, YOUNG ADULTS: 15-34). IN COUNTRIES WHERE AGE RANGES ARE MORE RESTRICTIVE, PREVALENCE ESTIMATES MAY TEND TO BE SLIGHTLY HIGHER. SOME COUNTRIES HAVE RECALCULATED THEIR PREVALENCE FIGURES USING THE EMCDDA STANDARD AGE GROUPS. 'SAMPLE SIZE' REFERS TO THE NUMBER OF ACTUAL RESPONDENTS TO THE SURVEY (NET SAMPLE). IN SOME CASES, NATIONAL SURVEYS COVER ORIGINALLY A BROADER AGE RANGE ('ORIGINAL AGE RANGE') THAN THAT PRESENTED HERE FOR THE STANDARD GROUPS 'ALL ADULTS'(15-64) AND 'YOUNG ADULTS' (15-34). THIS TABLE PRESENTS THE RESULTS FOR THE LAST SURVEYS AVAILABLE IN EACH COUNTRY. IT AIMS TO PRESENT AN OVERVIEW OF NATIONAL SURVEYS. SOME CITY SURVEYS REPORTED BY COUNTRIES WERE NOT INCLUDED AS THEY TEND TO PRODUCE HIGHER PREVALENCE ESTIMATES WHICH ARE NOT COMPARABLE WITH ESTIMATES FOR WHOLE COUNTRIES (OR LARGE REGIONS WITH BOTH URBAN AND RURAL AREAS).

ALL YOUNG ADULTS (15-34) USING CANNABIS IN EUROPE yearSample sizemalesfemalestotal Austria %15.70%19.20% Belgium %19.50%26.00% Bulgaria %10.00%15.60% Croatia %18.40%25.30% Denmark %40.50%45.90% Finland %25.10%29.00% France %36.97%45.10% Germany %30.40%35.30%

ALL YOUNG ADULTS (15-64) USING CANNABIS IN EUROPE MALE & FEMALE TOTAL AVERAGES

Countries were asked to report results using, as far as possible, EMCDDA standard age groups (all adults: 15-64, young adults: 15-34). In countries where age ranges are more restrictive, prevalence estimates may tend to be slightly higher. Some countries have recalculated their prevalence figures using the EMCDDA standard age groups. 'Sample size' refers to the number of actual respondents to the survey (Net sample). In some cases, national surveys cover originally a broader age range ('original age range') than that presented here for the standard groups 'All adults'(15-64) and 'Young adults' (15-34). This table presents the results for the last surveys available in each country. It aims to present an overview of national surveys. Some city surveys reported by countries were not included as they tend to produce higher prevalence estimates which are not comparable with estimates for whole countries (or large regions with both urban and rural areas). France: The most recent general population survey reported by Italy display a wide variation in results compared with the previous surveys which may reflect methodological differences. The data is provided for information, but given the lack of comparability between surveys should be treated with caution Germany: The most recent general population survey reported by the Netherlands display a wide variation in results compared with 2005 which may reflect methodological differences. The data is provided for information, but given the lack of comparability between surveys should be treated with caution